P458: HIPSC DISEASE MODELING TO STUDY LEUKEMIA DEVELOPMENT IN HAX1 VS ELANE ASSOCIATED CONGENITAL NEUTROPENIA

Podobne zapisy

• P1357: MILESTONE (MODIFYING ELANE GOLDBERG–HOGNES BOX TO INHIBIT EXPRESSION), A UNIVERSAL, SAFE AND EFFECTIVE CRISPR/CAS9N-MEDIATED GENOME EDITING STRATEGY FOR ELANE RELATED SEVERE CONGENITAL NEUTROPENIA
  od: Masoud Nasri, i wsp.
  Wydane: (2023-08-01)
• P458: HIPSC DISEASE MODELING TO STUDY LEUKEMIA DEVELOPMENT IN HAX1 VS ELANE ASSOCIATED CONGENITAL NEUTROPENIA
  od: Benjamin Dannenmann, i wsp.
  Wydane: (2023-08-01)
• Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring <i>ELANE</i> mutations
  od: Alexander Zeidler, i wsp.
  Wydane: (2023-10-01)
• CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients
  od: Masoud Nasri, i wsp.
  Wydane: (2020-03-01)
• P751: UNRAVELING THE DIFFERENT PATHOMECHANISMS OF CONGENITAL AND CYCLIC NEUTROPENIAS: CYCLIC EXPRESSION OF HEMATOPOIETIC STEM-CELL-SPECIFIC TRANSCRIPTION FACTORS IN CYCLIC NEUTROPENIA
  od: Karl Alexander Zeidler, i wsp.
  Wydane: (2023-08-01)